The Washington Post reported Sept. 23 that the FDA was expected to announce new standards for the emergency authorization of a COVID-19 vaccine this week, making it harder for a vaccine to be approved before Election Day.
“That has to be approved by the White House,” Mr. Trump said. “We may or may not approve it.”
He also suggested the FDA’s decision to revise the standards “was a political move more than anything else,” Politico reported.
The president repeatedly has claimed a COVID-19 vaccine would be available by Election Day, though some experts have said that’s extremely unlikely.
Read the full article here.
More articles on pharmacy:
FDA now requiring boxed warning for benzodiazepines
CVS accused of patient steering
HHS general counsel scolds Eli Lilly for halting 340B drug discounts
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.